Nasdaq:US$15.39 (+0.28) | HKEX:HK$24.20 (+0.00) | AIM:£2.29 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)